Simon Williams, PhD

Simon Williams, PhD
Simon Williams, PhD CEO of Akeso Biomedical

Recent Posts

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

Akeso Biomedical is pleased to announce that the European Food Safety Authority (EFSA) provided a positive scientific opinion for use of its CI-FER™ feed additive in weaners. The positive opinion was provided after the...

From The Corner Office: Akeso Biomedical Nears Commercial Sales Stage

As Akeso Biomedical embarks on its first in-the-field trials of its flagship product, CI-FERTM, it’s worthwhile looking back on the five-year journey that has taken us to this pivotal moment – years of product...

FEATURED RESOURCES

Insight
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Insight
Protecting Early Investors in Capital-Intensive Life Science Companies
Interview
Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan
White Paper
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
Updates
VIC 2021 Mid-Year Update Executive Summary
News
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
Interview
VIC Fellows Spotlight: Evan Goldberg, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission